DrugPatentWatch Database Preview
MAGNESIUM SULFATE Drug Profile
Email this page to a colleague
» See Plans and PricingWhich patents cover Magnesium Sulfate, and when can generic versions of Magnesium Sulfate launch?
Magnesium Sulfate is a drug marketed by Exela Pharma Scs Llc, Fresenius Kabi Usa, Hospira, Hospira Inc, Hq Spclt Pharma, and Mylan Labs Ltd. and is included in twelve NDAs.
The generic ingredient in MAGNESIUM SULFATE is magnesium sulfate. There are one hundred and forty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
US ANDA Litigation and Generic Entry Outlook for Magnesium Sulfate
A generic version of MAGNESIUM SULFATE was approved as magnesium sulfate by FRESENIUS KABI USA on September 8th, 1986.
Summary for MAGNESIUM SULFATE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 12 |
| Suppliers / Packagers: | 7 |
| Bulk Api Vendors: | 95 |
| Clinical Trials: | 193 |
| Patent Applications: | 1,386 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | MAGNESIUM SULFATE at DailyMed |
Recent Clinical Trials for MAGNESIUM SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Wright State University | Phase 4 |
| Kasr El Aini Hospital | N/A |
| Principal Investigator | Phase 4 |
Pharmacology for MAGNESIUM SULFATE
Medical Subject Heading (MeSH) Categories for MAGNESIUM SULFATE
Synonyms for MAGNESIUM SULFATE
| (C10-C16) Alkylalcohol sulfuric acid, magnesium salt |
| 18939-43-0 |
| 22189-08-8 |
| 68081-97-0 |
| 7487-88-9 |
| AB1009334 |
| ACMC-1CFPL |
| AI3-02029 |
| AKOS015902894 |
| Anhydrous magnesium sulfate |
| Arrosalt 2327 |
| Bitter salt |
| C10-C16 Alkyl alcohol sulfuric acid magnesium salt |
| Caswell No. 534 |
| CCRIS 8411 |
| CHEBI:32599 |
| CHEMBL2021423 |
| CSNNHWWHGAXBCP-UHFFFAOYSA-L |
| CTK3J2463 |
| DB00653 |
| DTXSID6042105 |
| EC 231-298-2 |
| EINECS 231-298-2 |
| EINECS 242-691-3 |
| EINECS 268-365-0 |
| EPA Pesticide Chemical Code 050503 |
| Epitope ID:158536 |
| FT-0628097 |
| HSDB 664 |
| J-014575 |
| J-519590 |
| K281 |
| KS-00000UUD |
| KSC492I6H |
| LS-88605 |
| M1890 |
| Magnesii sulfas |
| Magnesium sulfate (1:1) |
| Magnesium sulfate anhydrous |
| Magnesium sulfate dried |
| Magnesium sulfate dried pure, coarse |
| Magnesium Sulfate Heptahydrate Solution, 2.25% |
| Magnesium sulfate in dextrose 5% in plastic container |
| Magnesium Sulfate In Plastic Container |
| Magnesium sulfate, 97%, pure, anhydrous |
| Magnesium sulfate, 99%, extra pure, dried, contains 3 to 4 moles of water |
| Magnesium sulfate, 99%, for analysis, anhydrous |
| Magnesium sulfate, anhydrous |
| Magnesium sulfate, anhydrous granular |
| Magnesium sulfate, anhydrous powder |
| Magnesium sulfate, unspecified |
| Magnesium sulphate |
| Magnesium sulphate anhydrous |
| Magnesium(II) sulfate |
| Magnesiumsulfat |
| Magnesiumsulfate |
| MFCD00011110 |
| MFCD00149787 |
| MgO4S |
| MgSO4 |
| ML30MJ2U7I |
| NSC 146179 |
| OT-S |
| OT-S (drying agent) |
| Q288266 |
| RTR-024156 |
| Sal Angalis |
| Sal De sedlitz |
| SDA 15-062-07 |
| SN 00 |
| SR-01000944338 |
| SR-01000944338-1 |
| Sulfato de magnesio |
| Sulfuric acid magnesium salt |
| Sulfuric acid magnesium salt (1:1) |
| Sulfuric acid magnesium salt (VAN) |
| Sulfuric acid magnesiumsalt (1:1), hydrate (8CI,9CI) |
| Sulfuric acid, C10-16 alkyl ester, magnesium salt |
| Sulfuric acid, magnesium salt (1:1) |
| Sulfuric acid, mono-C10-16-alkyl esters, magnesium salts |
| sulphate of magnesia |
| Tomix OT |
| TR-024156 |
| TRA0075186 |
| UNII-DE08037SAB component CSNNHWWHGAXBCP-UHFFFAOYSA-L |
| UNII-ML30MJ2U7I |
US Patents and Regulatory Information for MAGNESIUM SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Labs Ltd | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209911-001 | Sep 14, 2018 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Mylan Labs Ltd | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209911-002 | Sep 14, 2018 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Exela Pharma Scs Llc | MAGNESIUM SULFATE | magnesium sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 206039-001 | Dec 18, 2014 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Hospira | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 020309-003 | Jan 26, 2007 | AP | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Hq Spclt Pharma | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 207350-002 | Dec 6, 2017 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Hospira Inc | MAGNESIUM SULFATE | magnesium sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 202411-001 | May 14, 2015 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
